• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

5 Undervalued Health Stocks


The stock market has been strong lately, leaving some investors to wonder if it has much life left in it. Goldman Sachs' chief U.S. equity strategist picked the stocks with huge upside potential that he expects to outperform the market.

The stock market has been on a tear lately (with a few minor bumps in the road). Some analysts believe that the market may be overvalued now and too expensive. However, Goldman Sachs’ chief U.S. equity strategist says there are still stocks he expects to outperform the market.

Business Insider has the full list of 40 stocks David Kostin says have the most upside potential and while the list is dominated by oil and gas firms, Goodyear, Amazon and Qualcomm make appearances. Still, half of the list is comprised of energy, mining and refining companies.

The 40 stocks on the list offer 23% to 57% upside relative to their recent prices, but here are the four health-related stocks to make it on the list.

5. Alexion

Ticker: ALXN

Sector: Pharmaceuticals

Upside: 24.5%

Recent price: $98

Alexion Pharmaceuticals is the original developer and distributor of Soliris, a drug used in treating the rare disorders Hemolytic-uremic syndrome and Paroxysmal nocturnal hemoglobinuria (PNH).

4. Eastman

Ticker: EMN

Sector: Pharmaceuticals

Upside: 24.5%

Recent price: $66.65

Eastman is a global specialty chemical company that produces a broad range of advanced materials, additives and functional products, specialty chemicals, and fibers that are found in products people use every day.

3. PerkinElmer

Ticker: PKI

Sector: Life sciences

Upside: 27.2%

Recent price: $30.65

Technology, services and solutions for applications such as environmental monitoring, food safety, clinical diagnostics and biomedical research.

2. Edwards Lifesciences

Ticker: EW

Sector: Biotech

Upside: 34.8%

Recent price: $63.79

Edwards Lifesciences designs, manufactures and markets tissue heart valves and related repair products.

1. Intuitive Surgical

Ticker: ISRG

Sector: Health technology

Upside: 38.9%

Recent price: $492.29

Intuitive Surgical designs and builds the da Vinci Surgical System for robotically assisted minimally invasive surgery.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice